Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755935 · ClinicalTrials.gov registry record · NA
CI532 - Early Experience Study
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02755935: Completed NA study, sponsored by Cochlear.
NCT02755935 is a NA study that has completed, run by Cochlear. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02755935, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate performance outcomes in patients implanted with the Cochlear Nucleus CI532 electrode array.
Primary Outcome
Unilateral listening performance at 3 months post activation with the CI532 compared to the best aided unilateral preoperative condition for sentence perception in quiet.
Interventions
- DEVICE Cochlear Nucleus CI532
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02755935 record still lists
NCT02755935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Cochlear Nucleus CI532 is the first listed.
NCT02755935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02755935 about?
NCT02755935 is a clinical study titled "CI532 - Early Experience Study". To evaluate performance outcomes in patients implanted with the Cochlear Nucleus CI532 electrode array.
What is the current status of trial NCT02755935?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-05. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02755935?
The interventions under investigation include: Cochlear Nucleus CI532 (DEVICE).
Who is sponsoring clinical trial NCT02755935?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02755935's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia